Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

LNDC Insider Trading

LIFECORE BIOMEDICAL, INC. DE | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at LIFECORE BIOMEDICAL, INC. DE provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2007-10-22 21:03 2007-10-19 FRANK FRED Director SELL $14.98 44,570 $667,512 397,744 -10.1%
2007-10-22 20:14 2007-10-19 JONES KENNETH E Director SELL $15.39 37,096 $570,996 405,763 -8.4%
2007-10-18 20:41 2007-10-17 FRANK FRED Director SELL $15.03 5,100 $76,670 442,314 -1.1%
2007-10-17 00:29 2007-10-16 FRANK FRED Director SELL $15.03 6,200 $93,162 447,414 -1.4%
2007-10-16 00:25 2007-10-15 JONES KENNETH E Director SELL $15.53 3,300 $51,257 442,859 -0.7%
2007-10-15 23:58 2007-10-15 FRANK FRED Director SELL $15.44 8,000 $123,557 453,614 -1.7%
2007-10-15 23:57 2007-10-15 FRANK FRED Director SELL $15.18 16,353 $248,243 461,614 -3.4%
2007-10-15 22:40 2007-10-12 SKINNER GREGORY S Officer - VP Finance and Admin & CFO OPT+S $15.90 39,772 $632,311 100,209 0.0%
2007-10-13 01:48 2007-10-12 JONES KENNETH E Director SELL $15.82 200 $3,164 446,159 0.0%
2007-10-13 01:47 2007-10-12 JONES KENNETH E Director SELL $15.55 156,800 $2,437,691 446,359 -26.0%
2007-10-13 00:30 2007-10-12 FRANK FRED Director SELL $15.52 23,700 $367,767 477,967 -4.7%
2007-10-05 23:16 2007-10-04 TOMPKINS NICHOLAS Director, Officer - Senior Vice President SELL $15.64 500,000 $7,820,300 451,446 -52.6%
2007-10-04 23:29 2007-10-04 HALPRIN STEPHEN E Director SELL $15.52 8,493 $131,831 47,742 -15.1%
2007-10-04 23:17 2007-10-04 STEELE GARY T Director, Officer - CEO and President SELL $15.75 50,000 $787,360 184,858 -21.3%
2007-10-04 22:15 2007-10-04 BITLER STEVEN P Officer - Vice President, Technology OPT+S $15.84 12,000 $190,081 27,135 0.0%
2007-10-04 22:13 2007-10-04 SKINNER GREGORY S Officer - VP Finance and Admin & CFO SELL $15.95 5,000 $79,750 2,911 -63.2%
2007-05-24 22:05 2007-04-20 FRANK FRED Director SELL $12.84 12,500 $160,444 500,000 -2.4%
2007-05-08 21:16 2007-05-07 FRANK FRED Director SELL $12.60 43,987 $554,051 512,500 -7.9%
2007-05-04 20:57 2007-05-02 FRANK FRED Director SELL $12.50 7,100 $88,750 556,487 -1.3%
2007-05-02 01:22 2007-04-30 FRANK FRED Director SELL $12.65 55,813 $706,129 563,587 -9.0%
2007-04-30 18:50 2007-04-26 FRANK FRED Director SELL $12.80 38,864 $497,374 619,400 -5.9%
2007-04-26 00:03 2007-04-24 FRANK FRED Director SELL $12.66 52,211 $660,981 658,264 -7.3%
2007-04-23 23:36 2007-04-23 FRANK FRED Director SELL $12.85 28,725 $369,257 710,475 -3.9%
2007-04-23 17:47 2007-04-19 FRANK FRED Director SELL $12.59 24,100 $303,378 739,200 -3.2%
2007-04-19 00:23 2007-04-18 FRANK FRED Director SELL $12.79 24,200 $309,564 763,300 -3.1%
2007-04-18 18:11 2007-04-17 FRANK FRED Director SELL $12.85 30,100 $386,920 787,500 -3.7%
2007-04-17 18:40 2007-04-16 SKINNER GREGORY S Officer - VP Finance and Admin & CFO OPT+S $13.00 2,000 $26,000 7,911 0.0%
2007-04-17 18:29 2007-04-16 FRANK FRED Director SELL $13.05 53,500 $697,913 817,600 -6.1%
2007-04-16 18:52 2007-04-13 FRANK FRED Director SELL $13.06 28,900 $377,524 871,100 -3.2%
2007-04-13 02:05 2007-04-12 TAFT DAVID D Officer - Chief Operating Officer OPT+S $13.02 30,000 $390,711 103,526 0.0%
2007-04-12 18:39 2007-04-11 STEELE GARY T Director, Officer - CEO and President SELL $13.02 11,700 $152,366 165,105 -6.6%
2007-04-10 23:34 2007-04-09 STEELE GARY T Director, Officer - CEO and President SELL $13.55 18,300 $247,952 176,805 -9.4%
2007-03-22 19:55 2007-03-20 TAFT DAVID D Officer - Chief Operating Officer OPT+S $13.45 18,262 $245,624 103,526 0.0%
2007-03-20 15:36 2007-03-19 TAFT DAVID D Officer - Chief Operating Officer OPT+S $13.45 1,738 $23,376 103,526 0.0%
2007-03-16 19:09 2007-03-14 TAFT DAVID D Officer - Chief Operating Officer OPT+S $12.75 10,786 $137,522 103,526 0.0%
2007-03-14 19:15 2007-03-13 TAFT DAVID D Officer - Chief Operating Officer OPT+S $12.62 33,249 $419,559 103,526 0.0%
2007-03-13 19:36 2007-03-12 TAFT DAVID D Officer - Chief Operating Officer OPT+S $13.01 15,965 $207,765 103,526 0.0%
2007-02-16 20:17 2007-02-15 FRANK FRED Director SELL $13.03 51,481 $670,664 164,670 -23.8%
2007-02-15 01:36 2007-02-14 FRANK FRED Director SELL $13.00 48,519 $630,757 216,151 -18.3%
2007-02-14 21:48 2007-02-13 FRANK FRED Director SELL $12.81 40,400 $517,702 264,670 -13.2%
2007-02-13 00:50 2007-02-12 FRANK FRED Director SELL $12.78 200,000 $2,556,460 305,070 -39.6%
2007-02-10 00:32 2007-02-09 FRANK FRED Director SELL $12.40 35,100 $435,128 505,070 -6.5%
2007-02-09 00:30 2007-02-08 FRANK FRED Director SELL $12.25 4,400 $53,919 542,170 -0.8%
2007-02-08 01:54 2007-02-07 FRANK FRED Director SELL $12.24 60,300 $737,903 546,570 -9.9%
2007-02-07 20:29 2007-02-06 FRANK FRED Director SELL $12.20 59,800 $729,303 606,870 -9.0%
2007-01-25 22:50 2007-01-24 BITLER STEVEN P Officer - Vice President, Technology OPT+S $12.00 3,667 $44,004 27,135 0.0%
2007-01-24 20:08 2007-01-23 SKINNER GREGORY S Officer - VP Finance and Admin & CFO OPT+S $12.00 3,000 $36,007 7,911 0.0%
2007-01-24 19:55 2007-01-23 BITLER STEVEN P Officer - Vice President, Technology OPT+S $12.04 6,333 $76,273 27,135 0.0%
2007-01-18 20:12 2007-01-17 FRANK FRED Director SELL $12.64 3,100 $39,181 1,566,670 -0.2%
2007-01-18 20:05 2007-01-17 FRANK FRED Director SELL $12.34 96,900 $1,195,329 1,569,770 -5.8%
SHOW ENTRIES

How to Interpret $LNDC Trades

Not every insider transaction in LIFECORE BIOMEDICAL, INC. DE is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $LNDC shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for LNDC

Insider activity data for LIFECORE BIOMEDICAL, INC. DE is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $LNDC, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.